ICD-10-CM Billable Code

F32.81

Premenstrual dysphoric disorder

Clinical Classification Guidelines

Excludes Type 1

  • premenstrual tension syndrome (N94.3)

Medical Intelligence & Overview

Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome that causes significant emotional and physical symptoms in women during their luteal phase, which is after ovulation and before the start of menstruation. Recognized under ICD-10 code F32.81, PMDD can interfere with daily life, relationships, and overall well-being. While many women experience mild premenstrual symptoms, PMDD involves more intense symptoms that warrant medical attention and management.

Causes & Symptoms

Clinical Causes: Hormonal fluctuations: Changes in estrogen and progesterone levels during the menstrual cycle are believed to influence PMDD symptoms. Genetic predisposition: A family history of mood disorders or PMDD can increase risk. Neurotransmitter sensitivity: Abnormalities or heightened sensitivity in brain chemicals such as serotonin may contribute to symptoms. Environmental and psychological factors: Stress, trauma, and mental health history can play a role in exacerbating symptoms.

Key Symptoms: Severe mood swings, including sudden feelings of sadness, irritability, or anger Marked anxiety or tension Depressed mood or feelings of hopelessness Persistent irritability or anger Decreased interest in usual activities or hobbies Difficulty concentrating or making decisions Fatigue or low energy Sleep disturbances, such as insomnia or oversleeping Physical symptoms like breast tenderness, headaches, joint or muscle pain, bloating, and weight changes

Diagnostic & Treatment

Diagnosis Path: Diagnosis of PMDD involves a thorough clinical assessment, typically based on the criteria outlined in the DSM-5. Healthcare providers often require the patient to keep a symptom diary over at least two menstrual cycles to document the timing and severity of symptoms. It is important to distinguish PMDD from mood disorders or other psychiatric conditions. Medical history, physical examination, and sometimes laboratory tests are used to rule out other causes of symptoms.

Treatment Protocols: Lifestyle modifications: Regular exercise, a balanced diet, adequate sleep, and stress management techniques such as mindfulness or yoga. Pharmacotherapy: Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), are commonly used and may be taken continuously or only during the premenstrual phase. Hormonal therapies: Birth control pills or other hormonal treatments may help regulate hormonal fluctuations and reduce symptoms. Nutritional supplements: Calcium, magnesium, vitamin B6, and may be considered in some cases to help manage symptoms. Psychotherapy: Cognitive-behavioral therapy (CBT) can be effective in managing emotional symptoms and improving coping strategies. Support groups and counseling: Providing emotional support and shared experiences may help women cope with PMDD.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F32.81 a billable ICD-10 code?
Yes, F32.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F32.81?
Clinical documentation must specify the nature of Premenstrual dysphoric disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

premenstrual dysphoric disorder